Advances in multiple sclerosis and experimental demyelinating diseases

Por Rodriguez, Moses.
Publicado em 2008

Seizures in Patients with Multiple Sclerosis: Epidemiology, Pathophysiology and Management

Por Kelley, Brendan J., Rodriguez, Moses
Publicado em 2009

Method of Identifying Natural Antibodies for Remyelination

Por Warrington, Arthur E., Rodriguez, Moses
Publicado em 2010

A New Humanized HLA Transgenic Mouse Model of Multiple Sclerosis Expressing Class II on Mouse CD4 T Cells

Por Mangalam, Ashutosh, Rodriguez, Moses, David, Chella
Publicado em 2007

Novel Roles of the Picornaviral 3D Polymerase in Viral Pathogenesis

Por Kerkvliet, Jason, Edukulla, Ramakrishna, Rodriguez, Moses
Publicado em 2010

Antiviral Effects of a Transgenic RNA-Dependent RNA Polymerase

Por Kerkvliet, Jason, Papke, Louisa, Rodriguez, Moses
Publicado em 2011

Is Multiple Sclerosis an Autoimmune Disease?

Por Wootla, Bharath, Eriguchi, Makoto, Rodriguez, Moses
Publicado em 2012

CD8(+) T Cells in Multiple Sclerosis

Por Denic, Aleksandar, Wootla, Bharath, Rodriguez, Moses
Publicado em 2013

Differential Influence of Interleukin-12 in the Pathogenesis of Autoimmune and Virus-Induced Central Nervous System Demyelination

Por Bright, John J., Rodriguez, Moses, Sriram, Subramaniam
Publicado em 1999

Absence of perforin expression confers axonal protection despite demyelination

Por Howe, Charles L., Adelson, Jaimie D., Rodriguez, Moses
Publicado em 2006

Invited Article: Human natural autoantibodies in the treatment of neurologic disease

Por Rodriguez, Moses, Warrington, Arthur E., Pease, Larry R.
Publicado em 2009

PDGF is Required for Remyelination-Promoting IgM Stimulation of Oligodendrocyte Progenitor Cell Proliferation

Por Watzlawik, Jens O., Warrington, Arthur E., Rodriguez, Moses
Publicado em 2013

Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple Sclerosis

Por Denic, Aleksandar, Wootla, Bharath, Zoecklein, Laurie, Rodriguez, Moses
Publicado no J Neurol Transl Neurosci (2013)

Need for a paradigm shift in therapeutic approaches to CNS injury

Por Wootla, Bharath, Denic, Aleksandar, Warrington, Arthur E, Rodriguez, Moses
Publicado em 2012

A monoclonal natural human IgM protects axons in the absence of remyelination

Por Wootla, Bharath, Denic, Aleksandar, Warrington, Arthur E., Rodriguez, Moses
Publicado no J Neuroinflammation (2016)

Concomitant Use of Neuroprotective Drugs in Neuro Rehabilitation of Multiple Sclerosis

Por Dasari, Harika, Wootla, Bharath, Warrington, Arthur E, Rodriguez, Moses
Publicado no Int J Phys Med Rehabil (2016)

Acute hemorrhagic demyelination in a murine model of multiple sclerosis

Por Rodriguez Moses, Suidan Georgette L, Pirko Istvan, Johnson Aaron J
Publicado em 2008-07-01

Genetic Deletion of a Single Immunodominant T‐cell Response Confers Susceptibility to Virus‐induced Demyelination

Por Pavelko, Kevin D., Pease, Larry R., David, Chella S., Rodriguez, Moses
Publicado em 2007

Acute hemorrhagic demyelination in a murine model of multiple sclerosis

Por Pirko, Istvan, Suidan, Georgette L, Rodriguez, Moses, Johnson, Aaron J
Publicado em 2008

Enhancing Central Nervous System Repair-The Challenges

Por Xu, Xiaohua, Warrington, Arthur E., Bieber, Allan J., Rodriguez, Moses
Publicado em 2011